References
Roman-Gomez J, Castillejo JA, Jimenez A, Gonzalez MG, Moreno F, Rodriguez MC et al. 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1gene and confers poor prognosis in acute lymphoblastic leukemia. Blood 2002; 99: 2291–2296.
Goyal J, Smith KM, Cowan JM, Wazer DE, Lee W, Band V . The role of NES1 serine protease as a novel tumor suppressor. Cancer Res 1998; 58: 4782–4786.
Li B, Goyal J, Dhar S, Goberdhan D, Evron E, Sukumar S et al. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res 2001; 61: 8014–8021.
Takeuchi S, Bartram CR, Wada M, Reiter A, Hatta Y, Seriu T et al. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995; 55: 5377–5382.
Malone CS, Miner MD, Doerr JR, Jackson JP, Jacobsen SE, Wall R et al. CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing. Proc Natl Acad Sci USA 2001; 98: 10404–10409.
Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M et al. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst 2001; 93: 1465–1472.
Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP et al. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res 2001; 7: 3393–3398.
Yousef GM, Diamandis EP . Expanded human tissue kallikrein family – a novel panel of cancer biomarkers. Tumor Biol 2002; 23: 185–192.
Acknowledgements
This work is supported by grants from Fondo de Investigaciones Sanitarias (FIS, Spain) 01/0662, 01/0013-01, 01/F018, 02/1299; Navarra Goverment (31/2002); RETIC C03/10 and funds from Cajamar-Fundacion Hospital Carlos Haya (Malaga, Spain).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X. et al. The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3–4, is downregulated by hypermethylation in acute lymphoblastic leukemia. Leukemia 18, 362–365 (2004). https://doi.org/10.1038/sj.leu.2403223
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403223
- Springer Nature Limited
This article is cited by
-
Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis
Molecular and Cellular Biochemistry (2023)
-
KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study
Journal of Ovarian Research (2018)
-
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
British Journal of Cancer (2009)
-
Emerging roles of proteases in tumour suppression
Nature Reviews Cancer (2007)
-
ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia
Oncogene (2006)